Insulin degludec versus insulin glargine U100 for patients with type 1 or type 2 diabetes in the US: a budget impact analysis with rebate tables

2017 ◽  
Vol 21 (2) ◽  
pp. 144-151 ◽  
Author(s):  
Wendy S. Lane ◽  
James Weatherall ◽  
Jens Gundgaard ◽  
Richard F. Pollock
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Impact Analysis ◽  
Budget Impact ◽  
Insulin Degludec ◽  
Budget Impact Analysis ◽  
The Us

scholarly journals PDB14 THE BUDGET IMPACT ANALYSIS OF VILDAGLIPTIN IN TYPE 2 DIABETES IN POLAND

2009 ◽  
Vol 12 (7) ◽  
pp. A403-A404 ◽  
Author(s):  
J Walczak ◽  
G Nogas ◽  
E Gebus ◽  
D Pawlik ◽  
K Pacocha
Keyword(s):  
Type 2 Diabetes ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis

scholarly journals Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands

2019 ◽  
Vol 4 (2) ◽  
pp. 321-330 ◽  
Author(s):  
Judith J. Gout-Zwart ◽  
Lisa A. de Jong ◽  
Lisanne Saptenno ◽  
Maarten J. Postma
Keyword(s):  
Type 2 Diabetes ◽  
The Netherlands ◽  
Sustained Release ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis

Budget impact analysis for dapagliflozin in type 2 diabetes in Egypt

2020 ◽  
Vol 23 (8) ◽  
pp. 908-914
Author(s):  
Gihan Hamdy Elsisi ◽  
Mohammed Moustapha Anwar ◽  
Mohamed Khattab ◽  
Ibrahim Elebrashy ◽  
Alaa Wafa ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis
Sign in / Sign up

Export Citation Format

Share Document